Author Archive

Telehealth Bill Could Improve Access to Care for Patients with Chronic Conditions

by Amanda Conschafter, blog editor A bipartisan bill from the U.S. House of Representatives might help seniors better manage chronic conditions. The Medicare Telehealth Parity

Read More

Patient Advocates Urge Congress to Act on National Pain Strategy

by Amanda Conschafter, blog editor A new plan to address chronic pain has garnered overwhelming support from patient advocates. The National Pain Strategy – developed

Read More

AfPA Biologics Summit Highlights Need for Patient Safety, Informed Physicians

by Amanda Conschafter, blog editor The Food and Drug Administration’s role is to determine a follow-on drug’s biosimilarity to its biologic predecessor, explained FDA’s Steven

Read More

The Alliance for Patient Access Calls for “Informed Drug Pricing”

by Brian Kennedy, Executive Director, Alliance for Patient Access A physician tells a story in the Alliance for Patient Access’ oncology working group white paper

Read More

IfPA Releases “Improving Access to Respiratory Care”

by Amanda Conschafter, blog editor Patients with respiratory conditions are often not sick enough to be in critical care but not well enough to deal

Read More

Patient Advocates Decry Florida’s “Discriminatory” Insurance Barriers to Hepatitis C Cures

by Amanda Conschafter, blog editor Health insurers who deny patients access to hepatitis C cures could be violating federal law, explains an April 5 letter

Read More

FDA’s Second Biosimilar Approval Hints at Random Naming System

by Amanda Conschafter, blog editor The Food and Drug Administration approved the second U.S. biosimilar on Tuesday, clearing the drug for seven different indications. Infliximab-dyyb

Read More

FDA’s Draft Biosimilar Labeling Guidance Falls Short on Patient Safety Measures

by Amanda Conschafter, blog editor The Food and Drug Administration has released its long-anticipated draft guidance on biosimilar labeling – but the document may leave

Read More

Indiana Tackles Step Therapy

by Amanda Conschafter, blog editor Indiana Governor Mike Pence has signed into law a bill restricting the use of step therapy – following in the

Read More

The Biosimilar Naming Dilemma

by Amanda Conschafter, blog editor Two months have passed since the World Health Organization released its final proposal on naming biological and biosimilar medications. Yet

Read More
Back to Top